Online citations, reference lists, and bibliographies.
← Back to Search

The Human High Mobility Group (HMG)-box Transcription Factor TCF-1: Novel Isoforms Due To Alternative Splicing And Usage Of A New Exon IXA.

K. M. Mayer, E. Wolff, H. Clevers, W. Ballhausen
Published 1995 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
The C-terminal peptide sequences of the human lymphocyte-specific high mobility group (HMG)-box transcription factor TCF-1 are determined by alternative splice mechanisms affecting the exons VIII to X. Here we report, in addition to four splice forms described previously (TCF-1A, B, C, D), the identification of three novel transcripts designated TCF-1E, F, G. Cloning and sequencing of the novel cDNAs revealed (i) joining of the exons VIII and IX to an internal exon X splice acceptor site resulting in a new open reading frame (ORF) of 99 amino acids derived from exon X sequences, (ii) the identification of an additional functional splice acceptor site within exon X, and (iii) a new 81-nucleotide insertion between exon VIII and exon X sequences in a novel transcript form. Genomic cloning and sequence analysis of this transcribed segment of 81 basepairs revealed that it was bordered by canonical splice consensus sites and located in a distance of some 400 bp from both the exons IX and X. It was therefore termed exon IXA. Novel ORFs were generated as a consequence of these alternative splice mechanisms resulting in TCF-1 gene products with significantly different C-terminal peptide sequences, which are prone to selective protein-protein interactions or transactivating functions.
This paper references
The DNA binding site of HMG1 protein is composed of two similar segments (HMG boxes), both of which have counterparts in other eukaryotic regulatory proteins.
M. Bianchi (1992)
Identification and cloning of TCF‐1, a T lymphocyte‐specific transcription factor containing a sequence‐specific HMG box.
M. Wetering (1991)
An essential cis-acting element of the lck-3' promoter regulates the expression of p56(lck) in metastatic colorectal-cancer cells.
K. M. Mayer (1993)
Nucleolar transcription factor hUBF contains a DNA-binding motif with homology to HMG proteins
H. Jantzen (1990)
Ancestry and diversity of the HMG box superfamily.
V. Laudet (1993)
An HMG-like protein that can switch a transcriptional activator to a repressor
N. Lehming (1994)
Alternative splicing in the control of gene expression.
C. Smith (1989)
Alternative splicing of fosB transcripts results in differentially expressed mRNAs encoding functionally antagonistic proteins.
D. Mumberg (1991)
Sequence‐specific interaction of the HMG box proteins TCF‐1 and SRY occurs within the minor groove of a Watson‐Crick double helix.
M. Wetering (1992)
Transcription factors in early T-cell development.
H. Clevers (1993)
Interaction between two homeodomain proteins is specified by a short C-terminal tail
Martha R. Stark (1994)
Similarity of human mitochondrial transcription factor 1 to high mobility group proteins.
M. Parisi (1991)
Sox‐4, an Sry‐like HMG box protein, is a transcriptional activator in lymphocytes.
M. Wetering (1993)
Alternative splicing of Pax-8 gene transcripts is developmentally regulated and generates isoforms with different transactivation properties.
Z. Kozmik (1993)
The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures
K. Giese (1992)
The human T cell transcription factor-1 gene. Structure, localization, and promoter characterization.
M. van de Wetering (1992)
More is better: Activators and repressors from the same gene
N. Foulkes (1992)

This paper is referenced by
Members of the T-Cell Factor Family of DNA-Binding Proteins and Their Roles in Tumorigenesis
A. Hecht (2004)
Predictive value of nuclear betacatenin expression for the occurrence of distant metastases in rectal cancer
K. Guenther (1998)
Ectopic activation of lymphoid high mobility group‐box transcription factor TCF‐1 and overexpression in colorectal cancer cells
K. Mayer (1997)
The human T-cell transcription factor-4 gene: structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines.
A. Duval (2000)
The Human T-Cell Transcription Factor-4 Gene : Structure , Extensive Characterization of Alternative Splicings , and Mutational Analysis in Colorectal Cancer Cell Lines 1
A Duval (2000)
Celecoxib-induced degradation of T-cell factors-1 and -4 in human colon cancer cells.
F. Takahashi‐Yanaga (2008)
Tcf-1 expression during Xenopus development.
Giulietta Roël (2003)
TCF transcription factors: molecular switches in carcinogenesis.
J. Roose (1999)
The Human T-Cell Transcription Factor-4 Gene : Structure , Extensive Characterization of Alternative Splicings , and Mutational Analysis in Colorectal Cancer Cell
E. Tubacher (2000)
Advances in Brief Frequent Frameshift Mutations of the TCF-4 Gene in Colorectal Cancers with Microsatellite Instability 1
A Duval (1999)
Peptide from Tat basic domain shows striking similarity to a region of human T cell transcription factor 1.
J. Nyhus (2003)
Isolation and expression analysis of a candidate gametophyte sex determination gene (sjhmg) of kelp (Saccharina japonica)
L. Zhang (2019)
Genetic Alterations in the Human Tcf-4 Gene in Japanese Patients with Sporadic Gastrointestinal Cancers with Microsatellite Instability
H. Saeki (2001)
TCF-1-mediated Wnt signaling regulates Paneth cell innate immune defense effectors HD-5 and -6: implications for Crohn's disease.
J. Beisner (2014)
Frequent frameshift mutations of the TCF-4 gene in colorectal cancers with microsatellite instability.
A. Duval (1999)
Forced expression of deltaN-TCF-1B in colon cancer derived cell lines is accompanied by the induction of CEACAM5/6 and mesothelin.
Beate Liebig (2005)
Intestinal Stem Cells in GI Physiology and Disease TCF-1-mediated Wnt signaling regulates Paneth cell innate immune defense effectors HD-5 and-6 : implications for Crohn ’ s disease
J. Beisner (2014)
Semantic Scholar Logo Some data provided by SemanticScholar